resTORbio, Inc. IPO Research Information

resTORbio, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on resTORbio, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
resTORbio, Inc.	TORC - NASDAQ	$14.00-$16.00	$15.00	$18.62	5.67 million	1/26/2018
Underwriter(s): BofA Merrill Lynch, Leerink Partners, Evercore ISI
Co-Manager(s): Wedbush PacGrow
Industry: Health Care
Filing(s): Filed 2017-12-29 Terms Added 2018-01-16 Final Prospectus 2018-01-29

resTORbio, Inc. Quote & Chart - Click for current quote - TORC

About resTORbio, Inc. (adapted from resTORbio, Inc. prospectus):
They are a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "TORC" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.